(Q35270646)

7 August 2017

Once-daily amikacin dosing in burn patients treated with continuous venovenous hemofiltration (English)

1 reference

7 August 2017

1 reference

3

Christopher R Frei

1 reference

7 August 2017

Kevin S Akers

1

1 reference

7 August 2017

Jason M Cota

2

1 reference

7 August 2017

Kevin K Chung

4

1 reference

7 August 2017

Katrin Mende

5

1 reference

7 August 2017

Clinton K Murray

6

1 reference

7 August 2017

language of work or name

English

0 references

publication date

8 August 2011

1 reference

Antimicrobial Agents and Chemotherapy

7 August 2017

1 reference

7 August 2017

55

1 reference

7 August 2017

10

1 reference

7 August 2017

4639-4642

1 reference

Amikacin monotherapy for sepsis caused by panresistant Pseudomonas aeruginosa

7 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186982

Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186982

Aminoglycoside resistance and susceptibility testing errors in Acinetobacter baumannii-calcoaceticus complex

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186982

The use of extended-interval aminoglycoside dosing strategies for the treatment of moderate-to-severe infections encountered in critically ill surgical patients

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186982

Continuous venovenous hemofiltration in severely burned patients with acute kidney injury: a cohort study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186982

Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186982

Suboptimal aminoglycoside dosing in critically ill patients

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186982

Antibiotic dosing in critically ill adult patients receiving continuous renal replacement therapy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186982

Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186982

Prospective randomized study of once-daily versus twice-daily amikacin regimens in patients with systemic infections

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186982

Efficacy and safety of once-daily amikacin in combination with ceftazidime in critically ill adults with severe gram-negative infections.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186982

Pharmacokinetics of antimicrobial agents in anuric patients during continuous venovenous haemofiltration.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186982

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186982

The necessity of increased doses of amikacin in burn patients

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186982

Tetracycline susceptibility testing and resistance genes in isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus complex from a U.S. military hospital

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186982

Continuous renal replacement therapy improves survival in severely burned military casualties with acute kidney injury

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186982

Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21825289

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pharmacokinetics of amikacin during continuous veno-venous hemofiltration

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21825289

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Increased amikacin dosage requirements in burn patients receiving a once-daily regimen

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21825289

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.00374-11

1 reference

7 August 2017

1 reference

7 August 2017

1 reference